Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Dopaminergic and Glutamatergic Neurotransmission for Dysfunctional Learning in Alcohol Use Disorders (LeAD P5)

NCT02094196 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.

NCT NCT02094196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02094196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Dopaminergic and Glutamatergic Neurotransmission for Dysfunctional Learning in Alcohol Use Disorders (LeAD P5)
Lead sponsor
Technische Universität Dresden
Phase
Observational
Overall status
Completed
Start date
December 31, 2012
Completion date
December 31, 2018
Enrollment
60 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder